REGISTER for February 4 Webinar
I-Corps from the Trenches:
Conversation with Pilot Participants
1:00 PM EST
Apply through PA-16-019 by March 21, 2016
SBIR and STTR Phase I grantees
are invited to join the I-Corps™ at NIH program. Part of President Obama’s Strategy for
American Innovation, I-Corps™ at NIH aims to support
biomedical innovation and translation, with the goal of expediting the
development and commercialization of technologies that address the
leading causes of death and disability in the United States. I-Corps™ participants will receive capacity building and entrepreneurial training,
mentorship opportunities, and modest funding to assist in translating ideas
from the lab into a viable product on the market and help avoid common failure
points.
For more information or questions on the I-Corps™ at NIH program, please visit http://sbir.cancer.gov/icorps/, watch
the archived webinar from November, or contact:
Jennifer C. Shieh, PhD, jennifer.shieh@nih.gov
Small Business Coordinator, Office of
Translational Alliances and Coordination, NHLBI
REGISTER for
February 16 Webinar
Bioreactors
for Reparative Medicine
2:00 PM
EST
February 20 - Stem Cell-Derived Blood Products for Therapeutic Use:
Technology Improvement
SBIR: RFA-HL-15-030,
Letters of intent due January
20
For tools and technologies
that enable further advances in the manufacturing process to produce safe and
functional blood and platelet products at reduced costs.
Watch the December webinar recording: Stem Cell-Derived Blood Products
for Therapeutic Use: Technology Improvement
Questions?
Contact:
Shimian Zou, PhD, shimian.zou@nih.gov
Program Director, Division of Blood Diseases and Resources
John
Thomas, PhD, thomasj@nhlbi.nih.gov
Program Director, Division of Blood Diseases and Resources
April 14 - Bioreactors for Reparative Medicine
Learn more at the webinar on
February 16, 2 PM EST: Bioreactors for Reparative Medicine
SBIR HL-15-008;
SBIR Direct to Phase 2 HL-15-017; STTR HL-15-004
To support multidisciplinary small business teams in the
development of complex, three-dimensional engineering systems for growing
heart, lung, or bone marrow tissue.
Notice Clarifying SBIR Direct-to-Phase II Eligibility
Criteria: NOT-OD-16-052
The NIH Direct-to-Phase II program will accept Phase II
submissions regardless of the funding source for the Phase I-like proof of
principle work on which the proposed Phase II research is based.
The Direct-to-Phase-II SBIR mechanism eliminates the need
for the SBCs to propose additional small feasibility studies, if the technology
is ready for the Phase II stage of development. The Direct-to-Phase II
authority is not available to the STTR program.
If you’re interested in the Direct-to-Phase II
program, check
out what to include in your 12 page Commercialization Plan (in the SF424
application guide, pg I-129) and take a look at our presentation on “Writing Your Phase II Commercialization Plan”.
Need NHLBI SBIR expert advice, please visit www.nhlbi.nih.gov/sbir and schedule a call with us at:
nhlbi_sbir@mail.nih.gov
Apply through PAR-14-088 by April 5, 2016
2/8 - 2/9 – BIO
CEO & Investor Conference – New York City, NY
2/14 - 2/17 – AUTM 2016 Annual
Meeting – San Diego, CA
2/20 - 2/23 – Cardiovascular Research Technologies (CRT)
2016 – Washington, DC
3/9 – Boston Biotech Conferences – Boston, MA
The NHLBI Small Biz Hangout on “How Pharma Evaluates New Therapeutic Opportunities”, which took place on October 13, 2015, is now available
for viewing online.
Check out the full playlist of NHLBI Small Biz
Hangouts on YouTube.
REGISTER for January 26 Webinar
NIH Small Business Programs:
What Biomedical Entrepreneurs Should Know
2:00 PM EST
Hosted by Women In Bio, this webinar will discuss the SBIR and STTR programs goals,
tips on applying, and resources available to researchers and small/startup
businesses interested in translating their technologies into commercial
products.
Presenters:
Kory Hallett, PhD
National Cancer Institute (NCI) SBIR
Development Center
Stephanie Fertig
National
Institute of Neurological Disorders and Stroke (NINDS) Office of Translational
Research
Any questions about the NIH Small Business programs can be sent
to nhlbi_sbir@mail.nih.gov.
|